GPHN p.Ser663Pro
c.1987T>C · rs762085852 · VCV1444945
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9985 | likely pathogenic |
|---|---|---|
| REVEL | 0.92 | moderately pathogenic-leaning |
| SaProt | LLR -11.84 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.8 | GERP 2.3, phastCons 1 |
| Regional constraint | o/e 0.68 | unconstrained · MANE · 110 kb · p 7.9e-10 · regional, not allelic |
| Overall | ||
| CADD | 31.0 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM S630P vs ClinVar S663P) — verify the residue.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 0.00781% | 12,804 |
| Remaining individualsnot grpmax-eligible | 0.00321% | 31,151 |
| European (non-Finnish)grpmax | 0.000766% | 130,532 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- GPHN
- Protein
- p.Ser663Pro
- Coding
- c.1987T>C
- MANE Select
- NM_020806
- dbSNP
- rs762085852
- Type
- single nucleotide variant
- Location
- chr14:67168944 (GRCh38)
- Gene constraint
- LOEUF 0.24 · pLI 1.00 · ClinGen HI 1/3 (gnomAD)
- Structure
- AlphaFold pLDDT 84.15 · 1 PDB
- Residue 630 UniProt numbering
- the 'mpt adenylyltransferase' region
Similar variants
- GPHN p.Ser663= Likely benign ★ same residue
- GPHN c.828+1G>A Likely pathogenic ★★ same condition
- GPHN p.Tyr56Ter Pathogenic/Likely pathogenic ★★ same condition
- GPHN c.1413+3A>G Uncertain significance ★★ same condition
- GPHN p.Ala239Thr Uncertain significance ★★ ⚠ same condition
- GPHN p.Ala448Ser Uncertain significance ★★ ⚠ same condition
- GPHN p.Ala55Ser Uncertain significance ★★ ⚠ same condition
- GPHN p.Ala590Ser Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gphn-p-ser663pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown